GSK3B and hepatocellular carcinoma: This study proposes a new mechanism of activated HSCs promoting the stem cell-like properties in residual HCC cells after incomplete thermal ablation through POSTN/integrin β1/AKT/GSK-3β/β-catenin/TCF4/Nanog signal pathway and metformin as a potential drug to reverse this process.